EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 29 March 2018

News

23032018 Statement in response to the EU Council ratifying the Brexit transition deal
23 March 2018

The associations representing the European and British life science industry have today responded to the European Council... Read more

Blogs

23032018 Inspiring health and growth in Greece
23 March 2018 - Nathalie Moll

Nathalie Moll's blog on the SFEE Annual General Assembly dinner Read more

23032018 Europe is awesome, its carrying the torch of medical innovation. We are proud to be...
23 March 2018 - Magda Chlebus

Don’t miss the train of IMI’s Call 14 - apply before 14 June Read more

27032018 Brexit and the potential impact on patients access to medicines and medical devices...
27 March 2018 - Elizabeth Kuiper

45 million patient packs go to the EU from the UK every month, and 37 million patient packs go from the EU to the UK... Read more

What we are reading

Better outcomes for all: can new pricing models transform European patient care?
On 27 March 2018 (POLITICO)

Flexible, innovative pricing models have the potential to deliver more sustainable healthcare services across Europe... Read more

Big Data for Better Outcomes Newsletter
On 22 February 2018 (BD4BO)

The BD4BO mission is to improve health outcomes and health care systems in Europe by maximising the potential of big... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu